Your gift today makes the research we fund possible and paves the way for a deeper understanding of these conditions, as well as better treatment options for those who need them.
window.bboxInit = function () {
bbox.…
FOR IMMEDIATE RELEASE
STAQ Pharma, Inc. has advised National Hemophilia Foundation and the Hemophilia Alliance and the of a typographical printing error on a few units of lot 21114255A Desmopressin Acetate 1.5 mg/mL.
This does not involve any…
FOR IMMEDIATE RELEASE
July 8, 2022
The patient advocacy organization has formally submitted a citizen’s petition to the Food and Drug Administration
On July 1, the National Hemophilia Foundation (NHF)…
Moanaro Biswas, PhD, is currently an Assistant Professor in the Gene and Cell Therapy Program at the Herman B Wells Center for Pediatric Research at Indiana University, Indianapolis. She was appointed to this position in May 2018. She received her…
You’re invited to participate in a free focus group with NHF that will help inspire future education resources related to joint health and pain management. Register now to join an insightful, online discussion on Thursday, July 21…
FOR IMMEDIATE RELEASEMEDIA CONTACT:Ilana Ostrin212 328 3769Patients, families and caregivers reunite at the 2022 Bleeding Disorders ConferenceJuly 12, 2022 - HOUSTON, TEXAS - After two years of coming together…
NEW YORK – Dr. Marion Koerper, a legendary pediatric hematologist, is solidifying her longtime relationship with the National Hemophilia Foundation thanks to a new research fund established in her honor.
Elevating a Future of…
NHF’s Medical and Scientific Advisory Council (MASAC) has approved a new recommendation on genotyping for people with hemophilia, which were endorsed by the NHF Board of Directors on July 6th.
The document provides a brief historic background of…